Fairmount Partners Assists Corealis CDMO in Completing Deal with ArchiMed

The significant recapitalization of the Americas’ leading CDMO for pharmaceutical oral solid dosage formulation and clinical supply manufacturing will accelerate growth, including the build-out of state-of-the-art laboratories and Good Manufacturing Practices-compliant facilities. May 24, 2022 – Trans-Atlantic private equity healthcare specialist ArchiMed is the lead investor in an alliance recapitalizing Corealis Pharma. ArchiMed and fellow […]